Treatment of mice with experimental allergic asthma with human recombinant tumstatin let to a significant reduction of hallmark disease features (e.g., airway hyperresponsiveness, ma-VEGF, eosinophil influx, IL13) (285). The gene discussed is IL13; the disease is allergic asthma.